Patterns and motivations of <i>Cannabis</i> use amongst patients with inflammatory bowel disease
Steven Pi(University of British Columbia), Yvette Leung(University of Calgary), Chris MacDonnell(Golder Associates (Canada)), C Enns(Golder Associates (Canada)), Brian Bressler(University of British Columbia), Robert Enns(University of British Columbia), Amy E. Wong(Golder Associates (Canada)), Greg Rosenfeld(British Columbia Centre on Substance Use)
Cited by 12
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478